CBR-2092

CBR-2092 is a dual-targeting antibacterial agent that potently inhibits bacterial RNA polymerase, DNA gyrase, and topoisomerase IV. This balanced mechanism retains activity against quinolone-resistant strains and is substantiated by genetic studies, making it a valuable tool for researching novel antibiotics and bacterial resistance mechanisms in vitro.

Product Specifications

CAS Number

922717-97-3

Field of Research

Cell Biology, Infectious Disease & Virology, Metabolism Research, Molecular Biology

Smiles

CO[C@H]1\C=C/O[C@@]2 (C) Oc3c (C2=O) c2c (O) c (C=NN4CCC (CC4) N (C) C4 (CC4) [C@@H]4CCN (C4) c4c (F) cn5c (c4C) c (cc (C (O) =O) c5=O) C4CC4) c (NC (=O) \C (C) =C/C=C\[C@H] (C) [C@H] (O) [C@@H] (C) [C@@H] (O) [C@@H] (C) [C@H] (OC (C) =O) [C@@H]1C) c (O) c2c (O) c3C |c:3,66,68|

Molecular Formula

C65H81FN6O15

Molecular Weight

1205.388

Storage Conditions

-20°C

Notes

For research use only.